Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1Genital Neoplasms, Female 1

Interventions

Educational Status 3pembrolizumab 2anlotinib 2Therapeutic Touch 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy 2Palliative Care 2Methods 2Interviews as Topic 2Early Intervention, Educational 2Carboplatin 2temsirolimus 1olaparib 1niraparib 1fosaprepitant 1argatroban 1Topotecan 1Thrombopoietin 1Surgical Procedures, Operative 1Practice Guidelines as Topic 1Palonosetron 1Paclitaxel 1Nivolumab 1Ipilimumab 1Heparin, Low-Molecular-Weight 1Filgrastim 1Dimenhydrinate 1Diffusion 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Genital Neoplasms, Female × argatroban × Clear all
NCT02935530 2019-05-14

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Huazhong University of Science and Technology

Phase 3 Completed
315 enrolled
Classical hematology

Genital Neoplasms, Female, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡